NEW ORLEANS — For contrast-enhanced imaging in multiple sclerosis (MS), all gadolinium-based agents accumulate in body tissue but to greatly varying degrees. While the long-term effect of gadolinium ...
Morning Overview on MSN
The FDA approved a lower-dose contrast agent to cut patients’ exposure during MRI scans
Patients who need repeated MRI scans with contrast dye could soon receive a fraction of the gadolinium they currently get.
Gadolinium-based contrast agents alone don't cause patients to develop nephrogenic systemic fibrosis
Even at very high doses, gadolinium-based contrast agents alone are not sufficient to cause nephrogenic systemic fibrosis (NSF) in patients with kidney problems, according to a study performed at the ...
Gadolinium-based contrast agents (GBCAs) used in MRI and angiography contain a chelated form of the toxic heavy metal that was assumed to clear the body shortly after intravenous administration. [1] ...
Please provide your email address to receive an email when new articles are posted on . Researchers have developed a potential alternative to gadolinium-based contrast agents for magnetic resonance ...
Adverse reactions from gadolinium-based contrast agents used during MRI rarely occur, study suggests
Acute adverse reactions from gadolinium-based contrast agents used during magnetic resonance imaging to help improve the information seen on the images rarely occur, according to a study. Acute ...
Expecting mothers who undergo an MRI in their first trimester shouldn’t have much to worry about if it was a standard one, according to a recent study of more than 1.4 million women. But an MRI that ...
The International Society for Magnetic Resonance in Medicine (ISMRM) has provided new guidance in the use of contrast agents during MRI scans. Emerging research suggests gadolinium-based contrast ...
The European Medicines Agency (EMA) on Friday said it plans to suspend the marketing authorization for three gadolinium contrast agents and restrict the use of others after a review by the agency's ...
An unexpected discovery surprised a scientist at the Max Planck Institute for Intelligent Systems in Stuttgart: Nanometer-sized diamond particles, which were intended for a completely different ...
A team of Massachusetts General Hospital (MGH) researchers has developed a potential alternative to gadolinium-based contrast agents (GBCAs) for magnetic resonance imaging (MRI). In their report that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results